EGFR and lung adenocarcinoma: Taken together with these previous findings, this case indicates that EGFR-mutated lung adenocarcinoma may maintain a long-term potential for reactivation even after an extended period of clinical remission, leading to recurrence through uncommon metastatic routes such as tumor-to-tumor metastasis to a meningioma.